Back to Journals » Infection and Drug Resistance » Volume 13

Is There Emergence of β-Lactam Antibiotic-Resistant Streptococcus pyogenes in China?

Authors Yu D, Zheng Y, Yang Y

Received 9 May 2020

Accepted for publication 25 June 2020

Published 14 July 2020 Volume 2020:13 Pages 2323—2327


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Suresh Antony

Dingle Yu,1,2,* Yuejie Zheng,2,* Yonghong Yang1,2

1Laboratory of Microbiology and Immunology, Beijing Children’s Hospital Affiliated to Capital Medical University, Beijing, People’s Republic of China; 2Department of Respiratory, Shenzhen Children’s Hospital, Shenzhen, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Yonghong Yang Email

Abstract: Streptococcus pyogenes is regarded as susceptible to β-lactam antibiotics. The guidelines of the Clinical and Laboratory Standards Institute (CLSI) are widely recognized and have long-recommended penicillin for treatment of S. pyogenes infections. There is no CLSI guideline for the treatment of S. pyogenes infections that have intermediate susceptibility or resistance to penicillin. However, there have been several reports of S. pyogenes isolates that are nonsusceptible or even resistant to β-lactam antibiotics, mostly from Chinese journals. The purpose of this commentary is to show data from the literature which suggests the presence of S. pyogenes isolates that are not susceptible to β-lactam antibiotics and whether these strains are really nonsusceptible to β-lactam antibiotics and the presence of mutation in the pbp2x gene requires further research and confirmation.

Keywords: Streptococcus pyogenes, GAS, β-lactam, antibiotic resistance, China

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]